The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.

Détails

Ressource 1Télécharger: BIB_D27AD59E764A.P001.pdf (471.64 [Ko])
Etat: Public
Version: de l'auteur⸱e
ID Serval
serval:BIB_D27AD59E764A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.
Périodique
American Journal of Human Genetics
Auteur⸱e⸱s
Hanson D., Murray P.G., Sud A., Temtamy S.A., Aglan M., Superti-Furga A., Holder S.E., Urquhart J., Hilton E., Manson F.D., Scambler P., Black G.C., Clayton P.E.
ISSN
1537-6605 (Electronic)
ISSN-L
0002-9297
Statut éditorial
Publié
Date de publication
2009
Volume
84
Numéro
6
Pages
801-806
Langue
anglais
Résumé
3-M syndrome is an autosomal-recessive primordial growth disorder characterized by significant intrauterine and postnatal growth restriction. Mutations in the CUL7 gene are known to cause 3-M syndrome. In 3-M syndrome patients that do not carry CUL7 mutations, we performed high-density genome-wide SNP mapping to identify a second locus at 2q35-q36.1. Further haplotype analysis revealed a 1.29 Mb interval in which the underlying gene is located and we subsequently discovered seven distinct null mutations from 10 families within the gene OBSL1. OBSL1 is a putative cytoskeletal adaptor protein that localizes to the nuclear envelope. We were also able to demonstrate that loss of OBSL1 leads to downregulation of CUL7, implying a role for OBSL1 in the maintenance of CUL7 protein levels and suggesting that both proteins are involved within the same molecular pathway.
Mots-clé
Adolescent, Cells, Cultured, Child, Child, Preschool, Cullin Proteins/genetics, Cytoskeletal Proteins/antagonists & inhibitors, Cytoskeletal Proteins/genetics, Cytoskeleton, Female, Growth Disorders/genetics, Humans, Infant, Kidney/cytology, Kidney/metabolism, Male, Mutation/genetics, Oligonucleotide Array Sequence Analysis, Pedigree, Polymorphism, Single Nucleotide/genetics, RNA, Small Interfering/pharmacology, Syndrome, Ubiquitination
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/03/2011 17:09
Dernière modification de la notice
20/08/2019 16:52
Données d'usage